Synspira

Synspira

Synspira

Synspira is developing a new class of glycopolymer-based therapeutics that have the potential to address a major unmet need associated with pulmonary disorders
Raised
$8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$8,000,000
Seed fund - 2017
Team Size
1–10
Employees
$8,000,000 Seed fund
businesswire

Synspira Announces $8 Million in Funding and Board of Directors